Search

Anna Pagonakis

Examiner (ID: 2415, Phone: (571)270-3505 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
OPET, 1614, 1609, 6221, 1628, 4173
Total Applications
1252
Issued Applications
445
Pending Applications
87
Abandoned Applications
723

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6292433 [patent_doc_number] => 20100239552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'Combination Therapies for Treating Metabolic Disorders' [patent_app_type] => utility [patent_app_number] => 12/724756 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 48200 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239552.pdf [firstpage_image] =>[orig_patent_app_number] => 12724756 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/724756
Combination Therapies for Treating Metabolic Disorders Mar 15, 2010 Abandoned
Array ( [id] => 10168166 [patent_doc_number] => 09198857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Growth promotion of animals by simultaneous release of steroid compounds from a device' [patent_app_type] => utility [patent_app_number] => 13/256286 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6421 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256286 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/256286
Growth promotion of animals by simultaneous release of steroid compounds from a device Mar 14, 2010 Issued
Array ( [id] => 6448205 [patent_doc_number] => 20100144886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'METHOD FOR TREATING PULMONARY ARTERIAL HYPERTENSION' [patent_app_type] => utility [patent_app_number] => 12/710133 [patent_app_country] => US [patent_app_date] => 2010-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13482 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144886.pdf [firstpage_image] =>[orig_patent_app_number] => 12710133 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/710133
METHOD FOR TREATING PULMONARY ARTERIAL HYPERTENSION Feb 21, 2010 Abandoned
Array ( [id] => 6431049 [patent_doc_number] => 20100143366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'ANTITUMOR AGENT' [patent_app_type] => utility [patent_app_number] => 12/707914 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5086 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143366.pdf [firstpage_image] =>[orig_patent_app_number] => 12707914 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/707914
ANTITUMOR AGENT Feb 17, 2010 Abandoned
Array ( [id] => 7651885 [patent_doc_number] => 20110301154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'SIGMA RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR MECHANISMS, EXHIBITING PROTOTYPICAL CYTOPROTECTIVE AND ALSO ANTICANCER ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/201271 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 1652 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301154.pdf [firstpage_image] =>[orig_patent_app_number] => 13201271 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/201271
SIGMA RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR MECHANISMS, EXHIBITING PROTOTYPICAL CYTOPROTECTIVE AND ALSO ANTICANCER ACTIVITY Feb 16, 2010 Abandoned
Array ( [id] => 7670100 [patent_doc_number] => 20110319369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'COMBINATION OF A 17 ALPHA-HYDROXYLASE/C17, 20-LYASE INHIBITOR WITH AN ADDITIONAL THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 13/146001 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11752 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13146001 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/146001
COMBINATION OF A 17 ALPHA-HYDROXYLASE/C17, 20-LYASE INHIBITOR WITH AN ADDITIONAL THERAPEUTIC AGENT Feb 4, 2010 Abandoned
Array ( [id] => 7586317 [patent_doc_number] => 20110280827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES' [patent_app_type] => utility [patent_app_number] => 13/146247 [patent_app_country] => US [patent_app_date] => 2010-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11933 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280827.pdf [firstpage_image] =>[orig_patent_app_number] => 13146247 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/146247
METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES Jan 27, 2010 Abandoned
Array ( [id] => 6520998 [patent_doc_number] => 20100203164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Therapeutic Treatment of Cancer and Dysplasia of the Cervix or Vagina Using Estrogen Antagonists' [patent_app_type] => utility [patent_app_number] => 12/693850 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9339 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203164.pdf [firstpage_image] =>[orig_patent_app_number] => 12693850 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/693850
Therapeutic treatment of cancer and dysplasia of the cervix or vagina using estrogen antagonists Jan 25, 2010 Issued
Array ( [id] => 6546544 [patent_doc_number] => 20100222312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF ASTHMA' [patent_app_type] => utility [patent_app_number] => 12/693565 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7306 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222312.pdf [firstpage_image] =>[orig_patent_app_number] => 12693565 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/693565
DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF ASTHMA Jan 25, 2010 Abandoned
Array ( [id] => 7683660 [patent_doc_number] => 20100240751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'Methods' [patent_app_type] => utility [patent_app_number] => 12/657301 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12335 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240751.pdf [firstpage_image] =>[orig_patent_app_number] => 12657301 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/657301
Methods Jan 18, 2010 Abandoned
Array ( [id] => 8173665 [patent_doc_number] => 20120108559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'RECEPTOR ACTIVATOR OF THE RANK RECEPTOR COMPLEX INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/144568 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3151 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108559.pdf [firstpage_image] =>[orig_patent_app_number] => 13144568 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/144568
RECEPTOR ACTIVATOR OF THE RANK RECEPTOR COMPLEX INHIBITOR Jan 6, 2010 Abandoned
Array ( [id] => 7657336 [patent_doc_number] => 20110306605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'COUMARIN-BASED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER\'S DISEASE AND CANCER' [patent_app_type] => utility [patent_app_number] => 13/140791 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 38291 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306605.pdf [firstpage_image] =>[orig_patent_app_number] => 13140791 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/140791
COUMARIN-BASED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND CANCER Dec 20, 2009 Abandoned
Array ( [id] => 7784686 [patent_doc_number] => 20120046242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY' [patent_app_type] => utility [patent_app_number] => 13/141838 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14147 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046242.pdf [firstpage_image] =>[orig_patent_app_number] => 13141838 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/141838
MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY Dec 20, 2009 Abandoned
Array ( [id] => 9427717 [patent_doc_number] => 08703792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'C-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation' [patent_app_type] => utility [patent_app_number] => 13/140209 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16082 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140209 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/140209
C-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation Dec 16, 2009 Issued
Array ( [id] => 6267518 [patent_doc_number] => 20100298377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'NOVEL SUBSTITUTED INDAZOLES, THE PREPARATION THEREOF AND USE OF SAME IN THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 12/636357 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34840 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298377.pdf [firstpage_image] =>[orig_patent_app_number] => 12636357 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/636357
NOVEL SUBSTITUTED INDAZOLES, THE PREPARATION THEREOF AND USE OF SAME IN THERAPEUTICS Dec 10, 2009 Abandoned
Array ( [id] => 8968912 [patent_doc_number] => 08507724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Compounds for use in the treatment of pain' [patent_app_type] => utility [patent_app_number] => 13/133569 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 14461 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133569 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/133569
Compounds for use in the treatment of pain Dec 8, 2009 Issued
Array ( [id] => 6212455 [patent_doc_number] => 20110135755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Combination therapies for treating neoplastic disease' [patent_app_type] => utility [patent_app_number] => 12/654047 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6970 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135755.pdf [firstpage_image] =>[orig_patent_app_number] => 12654047 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/654047
Combination therapies for treating neoplastic disease Dec 7, 2009 Abandoned
Array ( [id] => 6353344 [patent_doc_number] => 20100086553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'ANTITUMOR AGENT' [patent_app_type] => utility [patent_app_number] => 12/632182 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5080 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086553.pdf [firstpage_image] =>[orig_patent_app_number] => 12632182 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/632182
ANTITUMOR AGENT Dec 6, 2009 Abandoned
Array ( [id] => 7555523 [patent_doc_number] => 08067424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Selective inhibitors for cyclin-dependent kinases' [patent_app_type] => utility [patent_app_number] => 12/631373 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 46565 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067424.pdf [firstpage_image] =>[orig_patent_app_number] => 12631373 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/631373
Selective inhibitors for cyclin-dependent kinases Dec 3, 2009 Issued
Array ( [id] => 7581000 [patent_doc_number] => 20110294883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'ALPHA-DERIVATIVES OF CIS-MONOUNSATURATED FATTY ACIDS INTENDED FOR USE AS A DRUG' [patent_app_type] => utility [patent_app_number] => 13/132231 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16399 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294883.pdf [firstpage_image] =>[orig_patent_app_number] => 13132231 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/132231
α-Derivatives of cis-monounsaturated fatty acids intended for use as a drug Dec 3, 2009 Issued
Menu